Lista de obras -

A meta-analytic review of polyunsaturated fatty acid compositions in dementia.

artículo científico

Application of the Cockcroft-Gault method to estimate lithium dosage requirement.

artículo científico publicado en 2007

Aspirin and Risk of Dementia in Patients with Late-Onset Depression: A Population-Based Cohort Study

scientific article published on 29 January 2020

Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia

artículo científico publicado en 2011

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

artículo científico publicado en 2002

Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression

artículo científico publicado en 2012

Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression.

artículo científico publicado en 2011

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

artículo científico publicado en 2017

Challenge of caring for patients with severe mental illness during the COVID-19 epidemic in Taiwan

artículo científico publicado en 2020

Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy".

artículo científico publicado en 2005

Comparison of cognitive function between early- and late-onset late-life depression in remission

artículo científico publicado en 2020

Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

artículo científico publicado en 2018

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia

artículo científico publicado en 2004

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics

artículo científico publicado en 2018

Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release

artículo científico publicado en 2015

Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

artículo científico publicado en 2016

Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants

artículo científico publicado en 2003

Heavy smoking, reduced olanzapine levels, and treatment effects: a case report

artículo científico publicado en 2004

Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder

artículo científico publicado en 2019

Hypoalbuminemia in drug-free patients with major depressive disorder compared with a dietary matched control group: a clinical meaning beyond malnutrition

artículo científico publicado en 2005

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

artículo científico publicado en 2007

Methionine synthase 2756AA polymorphism is associated with the risk of cognitive impairment in patients with late-life depression

artículo científico publicado en 2016

Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life

scientific article published on 06 March 2019

Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.

artículo científico publicado en 2005

Omega-3 fatty acids for depression in pregnancy

artículo científico publicado en 2003

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

artículo científico publicado en 2003

Omega-3 fatty acids on the forced-swimming test

artículo científico publicado en 2006

Omega-3 polyunsaturated fatty acids for postpartum depression

artículo científico publicado en 2004

Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors

artículo científico publicado en 2008

Polyunsaturated fatty acid deficit in patients with bipolar mania

artículo científico publicado en 2003

Regular-dose risperidone on QTc intervals

artículo científico publicado en 2005

Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication

scientific article published on 06 November 2019

Subjective memory impairment in older adults: aetiology, salience and help seeking

artículo científico publicado en 2011

The association between subjective memory complaint and objective cognitive function in older people with previous major depression

artículo científico publicado en 2017

The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients

artículo científico publicado en 2006

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study

artículo científico publicado en 2008

The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder

artículo científico publicado en 2012

The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine

artículo científico publicado en 2010

pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase

artículo científico publicado en 2019

Lista de obras de

A meta-analytic review of polyunsaturated fatty acid compositions in dementia.

Application of the Cockcroft-Gault method to estimate lithium dosage requirement.

Aspirin and Risk of Dementia in Patients with Late-Onset Depression: A Population-Based Cohort Study

Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression

Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression.

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging

Challenge of caring for patients with severe mental illness during the COVID-19 epidemic in Taiwan

Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy".

Comparison of cognitive function between early- and late-onset late-life depression in remission

Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics

Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release

Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study

Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants

Heavy smoking, reduced olanzapine levels, and treatment effects: a case report

Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder

Hypoalbuminemia in drug-free patients with major depressive disorder compared with a dietary matched control group: a clinical meaning beyond malnutrition

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

Methionine synthase 2756AA polymorphism is associated with the risk of cognitive impairment in patients with late-life depression

Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life

Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.

Omega-3 fatty acids for depression in pregnancy

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Omega-3 fatty acids on the forced-swimming test

Omega-3 polyunsaturated fatty acids for postpartum depression

Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors

Polyunsaturated fatty acid deficit in patients with bipolar mania

Regular-dose risperidone on QTc intervals

Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication

Subjective memory impairment in older adults: aetiology, salience and help seeking

The association between subjective memory complaint and objective cognitive function in older people with previous major depression

The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study

The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder

The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine

pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase